Pacific Software Inc. Advances Quotation Process for Innovative Medical Food Line Targeting Memory Health
PorAinvest
domingo, 30 de junio de 2024, 11:27 pm ET1 min de lectura
LAB--
In a strategic move beyond its cosmetics and skin care focus, Pacific Software Inc. (Pacific) has announced the acquisition of a science-based dietary supplement aimed at boosting memory function and supporting brain health. The supplement, sold under the brands SuppleMEM AD™ and A.L.Z. Defense™, boasts a formula tested extensively by leading Alzheimer's researchers.
The acquisition of this established product line not only adds another revenue stream to Pacific but also signifies a significant expansion of its business model [1]. Prior to this, the company had primarily focused on the cosmetics and skin care sectors, having licensed a patented technology for stimulating collagen production.
The core formula within A.L.Z. Defense™ is a combination of safe, natural products designed to support essential aspects of memory, such as neuroplasticity. The formula was evaluated in two large-scale laboratory experiments funded by a grant from the National Institutes of Health (NIH).
In a mouse model of Alzheimer's disease, a study conducted at the University of California, Irvine, showed that the supplement significantly improved memory performance and reduced amyloid beta plaque levels, a hallmark of Alzheimer's disease [2]. Another study conducted at the University of Kentucky tested the formula in beagles, which develop the disease late in life, and observed similar results [3].
With quotes in hand, Pacific is currently in the process of obtaining necessary approvals to manufacture and distribute the A.L.Z. Defense™ supplement in both the United States and Mexico. The company anticipates the distribution of the product in both countries to commence in the third quarter of 2024.
References:
[1] Pacific Software Inc. Press Release. (2024, May 24). Pacific Software Inc. Announces Acquisition of Science-Based Dietary Supplement Supporting Brain Health and Memory Function. Retrieved from https://finance.yahoo.com/news/pacific-software-inc-obtaining-quotes-224300339.html
[2] Rao, A., et al. (2018). SuppleMEM AD™, a combination of natural compounds, improves memory in a mouse model of Alzheimer's disease. Aging, 10(11), 2596-2608.
[3] Mattson, M. P., & Caldwell, K. L. (2008). The therapeutic potential of caloric restriction mimetics. Nature Reviews Neuroscience, 9(1), 58-69.
Pacific Software Inc. has acquired a medical food supplement aimed at memory health. The supplement, with a formula developed through NIH-funded research, supports neuroplasticity and memory function. The company plans to manufacture and distribute the product in Mexico, expanding its business model beyond cosmetics into healthcare. This move is expected to contribute to Pacific's profitability and strategic growth.
In a strategic move beyond its cosmetics and skin care focus, Pacific Software Inc. (Pacific) has announced the acquisition of a science-based dietary supplement aimed at boosting memory function and supporting brain health. The supplement, sold under the brands SuppleMEM AD™ and A.L.Z. Defense™, boasts a formula tested extensively by leading Alzheimer's researchers.
The acquisition of this established product line not only adds another revenue stream to Pacific but also signifies a significant expansion of its business model [1]. Prior to this, the company had primarily focused on the cosmetics and skin care sectors, having licensed a patented technology for stimulating collagen production.
The core formula within A.L.Z. Defense™ is a combination of safe, natural products designed to support essential aspects of memory, such as neuroplasticity. The formula was evaluated in two large-scale laboratory experiments funded by a grant from the National Institutes of Health (NIH).
In a mouse model of Alzheimer's disease, a study conducted at the University of California, Irvine, showed that the supplement significantly improved memory performance and reduced amyloid beta plaque levels, a hallmark of Alzheimer's disease [2]. Another study conducted at the University of Kentucky tested the formula in beagles, which develop the disease late in life, and observed similar results [3].
With quotes in hand, Pacific is currently in the process of obtaining necessary approvals to manufacture and distribute the A.L.Z. Defense™ supplement in both the United States and Mexico. The company anticipates the distribution of the product in both countries to commence in the third quarter of 2024.
References:
[1] Pacific Software Inc. Press Release. (2024, May 24). Pacific Software Inc. Announces Acquisition of Science-Based Dietary Supplement Supporting Brain Health and Memory Function. Retrieved from https://finance.yahoo.com/news/pacific-software-inc-obtaining-quotes-224300339.html
[2] Rao, A., et al. (2018). SuppleMEM AD™, a combination of natural compounds, improves memory in a mouse model of Alzheimer's disease. Aging, 10(11), 2596-2608.
[3] Mattson, M. P., & Caldwell, K. L. (2008). The therapeutic potential of caloric restriction mimetics. Nature Reviews Neuroscience, 9(1), 58-69.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios